UNDERWRITING AGREEMENT between GLUCOSE HEALTH, INC., and EF HUTTON, DIVISION OF BENCHMARK INVESTMENTS, LLC AS REPRESENTATIVE OF THE SEVERAL UNDERWRITERSUnderwriting Agreement • January 9th, 2023 • Glucose Health, Inc. • Medicinal chemicals & botanical products • New York
The undersigned, Glucose Health, Inc., a company incorporated under the laws of the State of Delaware (the “Company”), hereby confirms its agreement (this “Agreement”) with EF Hutton, Division of Benchmark Investments, LLC, (hereinafter referred to as “you” (including its correlatives), or “EF Hutton” or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) for the purchase and sale of the Company’s common stock, par value $0.001 per share (the “Common Stock”) pursuant to the following terms:
Stock Purchase Agreement GLUCOSE HEALTH, INC.Stock Purchase Agreement • June 1st, 2022 • Glucose Health, Inc. • Medicinal chemicals & botanical products • Nevada
THIS STOCK PURCHASE AGREEMENT (the “Agreement”) is entered into effective as of June 17, 2020 (the “Closing Date”), by and between GLUCOSE HEALTH, INC., a Nevada corporation (the “Company”) and each of the purchasers as set forth on the signature pages hereof (each, a “Purchaser” and collectively, the “Purchasers”). Each of the Company and each Purchaser may be referred to herein individually as a “Party” and collectively as the “Parties.”
INDEPENDENT DIRECTOR AGREEMENTIndependent Director Agreement • August 5th, 2022 • Glucose Health, Inc. • Medicinal chemicals & botanical products • Delaware
This INDEPENDENT DIRECTOR AGREEMENT is dated August 1, 2022 (“Agreement”), by and between GLUCOSE HEALTH, INC, a Delaware corporation (the “Company”), and WILLIAM SIPPER, an individual (the “Director”).
April 7, 2014Termination of Marketing Services Agreement • April 15th, 2014 • Bio-Solutions Corp. • Grain mill products
Form of Lock-Up Agreement for Officers, Directors, and Holder(s) of more than 5% Common StockLock-Up Agreement • January 9th, 2023 • Glucose Health, Inc. • Medicinal chemicals & botanical products
PLAN AND AGREEMENT OF MERGER BETWEEN GLUCOSE HEALTH MERGER SUB, INC. (A DELAWARE CORPORATION) AND GLUCOSE HEALTH, INC. (A DELAWARE CORPORATION)Merger Agreement • June 1st, 2022 • Glucose Health, Inc. • Medicinal chemicals & botanical products • Delaware
THIS PLAN AND AGREEMENT OF MERGER (this “Agreement”) is entered into as of the ____ day of March, 2022, by and between Glucose Health Merger Sub, Inc., a Delaware corporation (“Merger Sub”), and Glucose Health, Inc., a Delaware corporation (the “Company”).
AGREEMENTAsset Purchase Agreement • November 22nd, 2011 • Bio-Solutions Corp. • Grain mill products • Nevada
THIS AGREEMENT ("Agreement") is made this 26 day of September, 2011, by and between BlO-Solutions Corp., a Nevada corporation ("BIO"), and Type2 Defense, a sole proprietorship based in Texas ("T2"), and the owner, William J. Gallagher of Type2 Defense ('T2") who is listed on Exhibit 1.1
AGREEMENTExclusive Marketing Agreement • June 1st, 2022 • Glucose Health, Inc. • Medicinal chemicals & botanical products • New Jersey
THIS AGREEMENT made and entered into as of February 1, 2022 (hereinafter referred to as the “Effective Date”), by and between CASCADIA MANAGING BRANDS, LLC, a Delaware Limited Liability Company, having its principal place of business at 120 East Main Street, Suite 375, Ramsey, NJ 07446 (“CMB”) and Glucose Health, Inc., a Nevada Corporation, having its principal place of business at 609 SW 8h Street, Suite 600, Bentonville AR 72712 (the “Company”).
MANAGEMENT CONSULTANT AGREEMENTManagement Consultant Agreement • October 2nd, 2014 • Bio-Solutions Corp. • Grain mill products • Nevada
THIS AGREEMENT is made as of October 1, 2014 between Bio-Solutions Corp. (“Company”) and Murray Fleming (“Consultant”) and all provisions set forth in this Agreement shall govern.
SERVICES AGREEMENTServices Agreement • June 1st, 2022 • Glucose Health, Inc. • Medicinal chemicals & botanical products • Nevada
THIS AGREEMENT, is made as of April 1, 2022, between Glucose Health, Inc. (“Company”) and BTB Management Company (“Consultant”) and super cedes a previous agreement dated July 1, 2021, between the Company and Murray Fleming, and all provisions set forth in this Agreement shall govern.
LICENCE AGREEMENT (this “Agreement”), entered in Montreal, Quebec, Canada, as of September 11, 2008.License Agreement • September 16th, 2008 • Bio-Solutions Corp. • Grain mill products • Quebec
WHEREAS ONS is interested in granting license rights to market and sell the ONS Product (as defined below) and to use the Trademarks (as defined below) in the Territory (as defined hereinafter);
EMPLOYMENT AGREEMENTEmployment Agreement • August 18th, 2009 • Bio-Solutions Corp. • Grain mill products • Quebec
This EMPLOYMENT AGREEMENT (“ Agreement”) dated as of August 17th, 2009, (the "Effective Date") is entered into by and between Bio-Solutions Corp., a Nevada corporation located 14517 Joseph Marc Vermette, Mirabel, Province of Quebec, J7J 1X2_( the “Company”), and Gilles Chaumillon, PhD, MBA , an individual residing at 141, rue Ovila, Rosemère, Province of Quebec, Canada, J7A 4L2. (the "Executive").
SERVICES AGREEMENTServices Agreement • September 6th, 2022 • Glucose Health, Inc. • Medicinal chemicals & botanical products • Nevada
THIS AGREEMENT is made as of July 1, 2021, between Glucose Health, Inc. (“Company”) and BTB Management Company (“Consultant”) and super cedes a previous agreement dated October 1, 2014, between the Company and Murray Fleming, and all provisions set forth in this Agreement shall govern.
THIS INTELLECTUAL PROPERTY PURCHASE AGREEMENT (the "Agreement") dated this 1st day of October 2014 (the “Effective Date”), BETWEEN:Intellectual Property Purchase Agreement • October 2nd, 2014 • Bio-Solutions Corp. • Grain mill products • Wyoming
IN CONSIDERATION OF THE COVENANTS and agreements contained in this Agreement, the parties to this Agreement agree as follows:
Stock Purchase Agreement GLUCOSE HEALTH, INC. (Purchaser)Stock Purchase Agreement • June 1st, 2022 • Glucose Health, Inc. • Medicinal chemicals & botanical products • Nevada
THIS STOCK PURCHASE AGREEMENT (the “Agreement”) is entered into as of May 1, 2019 (the “Effective Date”), by and between GLUCOSE HEALTH, INC., a Nevada corporation (the “Company”) and [ ] (“Purchaser”). Each of the Company and Purchaser may be referred to herein individually as a “Party” and collectively as the “Parties.”
